UA60133A - Способ диагностики осложнений вирусных гепатитов - Google Patents
Способ диагностики осложнений вирусных гепатитов Download PDFInfo
- Publication number
- UA60133A UA60133A UA2003020928A UA200320928A UA60133A UA 60133 A UA60133 A UA 60133A UA 2003020928 A UA2003020928 A UA 2003020928A UA 200320928 A UA200320928 A UA 200320928A UA 60133 A UA60133 A UA 60133A
- Authority
- UA
- Ukraine
- Prior art keywords
- complications
- concentration
- viral hepatitis
- blood
- diagnosing
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 206010019799 Hepatitis viral Diseases 0.000 title claims abstract description 17
- 201000001862 viral hepatitis Diseases 0.000 title claims abstract description 17
- 210000002966 serum Anatomy 0.000 claims description 9
- 238000009534 blood test Methods 0.000 claims description 3
- 238000012876 topography Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 238000012742 biochemical analysis Methods 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 description 11
- 238000003745 diagnosis Methods 0.000 description 10
- 210000003445 biliary tract Anatomy 0.000 description 6
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
- UNKYOXKQMHLGPW-UHFFFAOYSA-N Urobilin IXalpha Natural products CCC1=C(C)C(=O)NC1CC2=NC(=Cc3[nH]c(CC4NC(=O)C(=C4C)CC)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O UNKYOXKQMHLGPW-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 238000004159 blood analysis Methods 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000002559 palpation Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- KDCCOOGTVSRCHX-UHFFFAOYSA-N urobilin Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(CC3C(=C(CC)C(=O)N3)C)=N2)CCC(O)=O)N1 KDCCOOGTVSRCHX-UHFFFAOYSA-N 0.000 description 2
- 206010049634 Cholecystocholangitis Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010025280 Lymphocytosis Diseases 0.000 description 1
- 206010029379 Neutrophilia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 238000004223 overdiagnosis Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Способ диагностики осложнений вирусных гепатитов осуществляется путем проведения биохимического исследования крови. В соответствии с изобретением определяют содержание молекул средней молекулярной массы в сыворотке крови. Наличие осложнений диагностируют при их содержании в 3,0 г/л и выше.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2003020928A UA60133A (ru) | 2003-02-03 | 2003-02-03 | Способ диагностики осложнений вирусных гепатитов |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2003020928A UA60133A (ru) | 2003-02-03 | 2003-02-03 | Способ диагностики осложнений вирусных гепатитов |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA60133A true UA60133A (ru) | 2003-09-15 |
Family
ID=74220910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2003020928A UA60133A (ru) | 2003-02-03 | 2003-02-03 | Способ диагностики осложнений вирусных гепатитов |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA60133A (ru) |
-
2003
- 2003-02-03 UA UA2003020928A patent/UA60133A/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Theel et al. | Molecular and direct detection tests for Treponema pallidum subspecies pallidum: a review of the literature, 1964–2017 | |
| ES2612482T3 (es) | Marcadores en la orina para la detección del cáncer de vejiga | |
| Ryback et al. | Biochemical and hematologic correlates of alcoholism and liver disease | |
| CN101124340A (zh) | 血液淋巴细胞中子宫内膜异位症的分子诊断标志物的鉴定 | |
| CA2242493A1 (en) | Methods of screening for ulcerative colitis by detecting an interleukin-1 receptor antagonist polymorphism | |
| CN108135982A (zh) | 治疗克罗恩病的方法 | |
| EP1132483A2 (en) | Method for diagnosing schizophrenia using objective indices | |
| AU2018253505B2 (en) | Methods and kits for detecting kawasaki disease and methods for treating kawasaki disease | |
| King et al. | Serum total IgE and specific IgE to Dermatophagoides pteronyssinus, but not eosinophil cationic protein, are more likely to be elevated in elderly asthmatic patients. | |
| RU2445915C1 (ru) | Способ прогнозирования риска снижения уровня резистентности организма к острым респираторным заболеваниям у детей в возрасте 3-7 лет по индексу авидности секреторного иммуноглобулина а | |
| UA60133A (ru) | Способ диагностики осложнений вирусных гепатитов | |
| JP3771502B2 (ja) | 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法 | |
| JP2007509331A (ja) | アルツハイマー病の診断のための迅速な試験 | |
| CN104105967B (zh) | 生腱蛋白c及其在类风湿关节炎的用途 | |
| RU2688209C1 (ru) | Способ прогнозирования характера течения изолированной формы акантолитической пузырчатки полости рта | |
| WO2003012140A1 (fr) | Methode d'analyse d'acide nucleique specifiant un gene presentant un changement de dose d'expression en schizophrenie | |
| RU2684727C1 (ru) | Способ диагностики острого аппендицита с клинической симптоматикой, имитирующей правостороннюю почечную колику | |
| RU2137137C1 (ru) | Способ определения m.leprae у больных с регрессом заболевания | |
| Horowitz | The olfactory sense and its clinical applications | |
| US11965879B2 (en) | Method for diagnosing and assessing endometriosis | |
| RU2739997C1 (ru) | Способ выявления и лабораторного подтверждения наследуемого хромосомно-интегрируемого вируса герпеса человека 6A/B | |
| RU2456603C1 (ru) | Способ прогнозирования развития смешанной клещевой энцефалит-боррелиозной инфекции | |
| RU2642723C2 (ru) | Способ выявления больных с впервые возникшими приступами острой порфирии | |
| US10802030B2 (en) | Systems and methods to predict risk for preterm labor and/or preterm birth | |
| CN101586165A (zh) | 检测OTOF基因2975-2978delAG突变的试剂盒 |